Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

Generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline, five sources familiar with the matter said.

http://in.reuters.com/article/2014/07/22/uk-gsk-disposal-idINKBN0FR18L20140722

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING